[SCI] (Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society)
/ 2019.01.01

[SCI] (Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane)
/ 2018.01.01

[SCI] (Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer)
/ 2018.01.01

[SCI] (Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer)
/ 2018.01.01

[SCI] (Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer)
/ 2018.01.01

[SCI] (Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database)
/ 2018.01.01

[SCI] (Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database)
/ 2018.01.01

[SCI] (Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer)
/ 2018.01.01

[SCI] (Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype)
/ 2018.01.01

[SCI] (Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells)
/ 2017.01.01

[SCI] (Wild-type p53 controls the level of fibronectin expression in breast cancer cells)
/ 2017.01.01

[SCI] (Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer)
/ 2017.01.01

[SCI] (Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study)
/ 2017.01.01

[SCI] (Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study)
/ 2017.01.01

[SCI] (Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea)
/ 2017.01.01